“What’s Hot: Key Issues & Regulatory Affairs” – panel discussion at the second annual
Global Pharma Manufacturing Summit. The panel will focus on drug manufacturing,
safety, and alignment with the new direction of the Food & Drug Administration (FDA).
September 26, 2006, 10:40 am
Horseshoe Bay Resort Marriott Hotel, Austin, Texas
Tom Knight, Founder & Chief Strategy Officer, Invistics Corporation
Jill Wechsler, Washington Editor, Pharmaceutical Technology Magazine
Dr. Mel Koch, Director, Center for Process Analytical Chemistry
Dave Haggard, Director, Divisional GMP Auditing, Merck & Co.
Dr. Fernando Muzzio, Professor, Director, NSF Engineering Research Center for
Structured Organic Composites, Rutgers University
The Global Pharma Manufacturing Summit 2006 brings together North America’s most respected pharmaceutical manufacturing professionals to discuss the latest news and trends on how to innovate and streamline manufacturing operations.
Tom Knight, founder and chief strategy officer of Invistics, is participating on the panel as an expert in helping demand-driven manufacturers successfully adapt Lean manufacturing methods to improve performance. By addressing the variability that is synonymous with complex, asset intensive manufacturing environments, Invistics MachSix™ software can help pharmaceutical makers to reduce cycle times and excess inventory, while increasing throughput and improving customer service. MachSix is an enhancement to ERP functionality and integrates with other systems to improve manufacturing performance and break down traditional operational silos.
For more information about Invistics, please visit www.invistics.com.